Back to search
Ventricular Septal Defect
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Ventricular Septal Defect trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Ventricular Septal Defect trials you may qualify forThe Abbott Structural Heart (SH) Registry is being conducted to confirm the safety and performance of Abbott's SH devices in a post-market, real-world setting.…
The goal of this observational study is to develop and validate a multimodal artificial intelligence prediction model for treatment-related complications in chi…
This study will demonstrate the safety and effectiveness of the Edwards Lifesciences SAPIEN 3/SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve (THV) Systems in…
The Occlutech® mVSD is indicated for percutaneous occlusion of hemodynamically or clinically significant muscular ventricular septal defects. The objectives of…
The goal of this clinical trial is to learn if a specific type of exercise training (high intensity interval training) can improve exercise capacity in people w…
Heart failure is a common long-term complication in patients with congenital heart disease (CHD). Medical treatments to promote regeneration of new healthy hear…
Establish a cardiovascular biomarker profile to help screening for congenital heart disease in infants and children as well as use non-invasive cardiac imaging…
Currently, research on the effect of thiamine administration during transcatheter closure on the structure and function of the left ventricle by examining level…
Ventricular septal defect (MI-VSD) is a serious mechanical complication of acute myocardial infarction, with an extremely high mortality. Intra-aortic balloon p…